 |
Viatris
VTRS
|
$ 15.09
|
18.1 B
|
$ 172 M
|
-5.3
|
1.3
|
$ -2.8
|
 |
 |
Tilray
TLRY
|
$ 7.37
|
4.55 B
|
$ -105 M
|
-3.2
|
5.5
|
$ -2.3
|
 |
 |
Bausch Health Companies
BHC
|
$ 5.77
|
2.11 B
|
$ 3.23 B
|
-5.2
|
0.2
|
$ -1.1
|
 |
 |
Perrigo Company plc
PRGO
|
$ 11.38
|
1.58 B
|
$ 579 M
|
-54.2
|
0.4
|
$ -0.2
|
 |
 |
Harrow Health
HROW
|
$ 38.95
|
1.43 B
|
$ 17.6 M
|
-86.6
|
6.2
|
$ -0.4
|
 |
 |
Cronos Group
CRON
|
$ 2.62
|
1.36 B
|
∙ |
∙ |
∙ |
∙ |
 |
 |
Pacira BioSciences
PCRX
|
$ 22.06
|
1.02 B
|
$ -75.6 M
|
-7.4
|
1.5
|
$ -3.0
|
 |
 |
Assertio Holdings
ASRT
|
$ 11.92
|
847 M
|
$ -3.27 M
|
-54.2
|
6.3
|
$ -0.2
|
 |
 |
Emergent BioSolutions
EBS
|
$ 8.87
|
454 M
|
$ -238 M
|
-1.2
|
0.4
|
$ -7.5
|
 |
 |
Organogenesis Holdings
ORGO
|
$ 2.86
|
377 M
|
$ 2.42 M
|
-40.9
|
0.8
|
$ -0.1
|
 |
 |
Veru
VERU
|
$ 2.54
|
343 M
|
$ -31.2 M
|
-1.8
|
25.2
|
$ -1.4
|
 |
 |
Evolus
EOLS
|
$ 4.21
|
261 M
|
$ -48.4 M
|
-3.8
|
1.0
|
$ -1.1
|
 |
 |
Solid Biosciences
SLDB
|
$ 5.99
|
244 M
|
$ -115 M
|
-2.6
|
12.4
|
$ -2.3
|
 |
 |
Relmada Therapeutics
RLMD
|
$ 4.67
|
141 M
|
$ -165 M
|
-2.4
|
-131.2
|
$ -1.9
|
 |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 4.5
|
63.3 M
|
$ 1.01 M
|
-21.4
|
1.6
|
$ -0.2
|
 |
 |
SCYNEXIS
SCYX
|
$ 0.73
|
34.9 M
|
$ -72.9 M
|
-1.5
|
13.4
|
$ -0.5
|
 |
 |
TherapeuticsMD
TXMD
|
$ 2.26
|
23.6 M
|
$ -3.18 M
|
-45.2
|
8.8
|
$ -0.0
|
 |
 |
Rockwell Medical
RMTI
|
$ 0.9
|
21 M
|
$ 1.12 M
|
-22.5
|
0.2
|
$ -0.0
|
 |
 |
China Pharma Holdings
CPHI
|
$ 0.55
|
9.61 M
|
$ -1.98 M
|
-0.4
|
2.4
|
$ -1.2
|
 |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 2.76
|
3.43 M
|
$ -5.22 M
|
-1.3
|
0.2
|
$ -2.2
|
 |
 |
cbdMD
YCBD
|
$ 0.79
|
3.41 M
|
$ -1.22 M
|
-0.2
|
0.2
|
$ -3.9
|
 |